| Real-world survival outcomes associated with first-line immunotherapy, targeted therapy, and combination therapy for metastatic clear cell renal cell carcinoma NH Chakiryan, DD Jiang, KA Gillis, E Green, A Hajiran, L Hugar, L Zemp, ... JAMA Network Open 4 (5), e2111329-e2111329, 2021 | 37 | 2021 |
| Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response A Hajiran, N Chakiryan, AM Aydin, L Zemp, J Nguyen, JM Laborde, ... Clinical & Experimental Immunology 204 (1), 96-106, 2021 | 32 | 2021 |
| Secondary pelvic congestion syndrome: description and radiographic diagnosis. AG Winer, NH Chakiryan, RP Mooney, D Verges, M Ghanaat, A Allaei, ... The Canadian journal of urology 21 (4), 7365-7368, 2014 | 28 | 2014 |
| Pathological downstaging and survival outcomes associated with neoadjuvant chemotherapy for variant histology muscle invasive bladder cancer NH Chakiryan, DD Jiang, KA Gillis, E Green, A Hajiran, L Hugar, L Zemp, ... The Journal of Urology 206 (4), 924-932, 2021 | 27 | 2021 |
| A targetable myeloid inflammatory state governs disease recurrence in clear-cell renal cell carcinoma PM Rappold, L Vuong, J Leibold, NH Chakiryan, M Curry, F Kuo, E Sabio, ... Cancer discovery 12 (10), 2308-2329, 2022 | 26 | 2022 |
| Spatial Clustering of CD68+ Tumor Associated Macrophages with Tumor Cells is Associated with Worse Overall Survival in Metastatic Clear Cell Renal Cell Carcinoma NH Chakiryan, G Kimmel, Y Kim, A Hajiran, A Aydin, L Zemp, E Katende, ... PLoS One, 2021 | 24 | 2021 |
| Survival outcomes associated with cytoreductive nephrectomy in patients with metastatic clear cell renal cell carcinoma NH Chakiryan, LR Gore, RR Reich, RL Dunn, DD Jiang, KA Gillis, ... JAMA Network Open 5 (5), e2212347-e2212347, 2022 | 23 | 2022 |
| spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data JH Creed, CM Wilson, AC Soupir, CM Colin-Leitzinger, GJ Kimmel, ... Bioinformatics 37 (23), 4584-4586, 2021 | 22 | 2021 |
| Optimizing the sequence of chemotherapy for upper tract urothelial carcinoma with clinically positive regional lymph nodes N Chakiryan, A Martinez, L Gao, JJ Liu, C Amling, M Garzotto, RP Kopp The Journal of Urology 202 (1), 76-82, 2019 | 19 | 2019 |
| Correlating immune cell infiltration patterns with recurrent somatic mutations in advanced clear cell renal cell carcinoma NH Chakiryan, A Hajiran, Y Kim, AM Aydin, L Zemp, E Katende, J Nguyen, ... European urology focus 8 (3), 784-793, 2022 | 17 | 2022 |
| Quantification of T-and B-cell immune receptor distribution diversity characterizes immune cell infiltration and lymphocyte heterogeneity in clear cell renal cell carcinoma MC Ferrall-Fairbanks, NH Chakiryan, BI Chobrutskiy, Y Kim, JK Teer, ... Cancer research 82 (5), 929-942, 2022 | 16 | 2022 |
| Patterns of recurrence following inguinal lymph node dissection for penile cancer: optimizing surveillance strategies NH Chakiryan, A Dahmen, M Bandini, F Pederzoli, L Marandino, ... The Journal of urology 206 (4), 960-969, 2021 | 16 | 2021 |
| Geospatial cellular distribution of cancer-associated fibroblasts significantly impacts clinical outcomes in metastatic clear cell renal cell carcinoma NH Chakiryan, GJ Kimmel, Y Kim, JO Johnson, N Clark, A Hajiran, ... Cancers 13 (15), 3743, 2021 | 16 | 2021 |
| Proteogenomic, epigenetic, and clinical implications of recurrent aberrant splice variants in clear cell renal cell carcinoma A Chang, NH Chakiryan, D Du, PA Stewart, Y Zhang, Y Tian, AC Soupir, ... European urology 82 (4), 354-362, 2022 | 15 | 2022 |
| Relative value units do not adequately account for operative time of urological surgery NH Chakiryan, DD Jiang, KA Gillis, Y Chen, AM Acevedo, KP Sajadi Journal of Urology 203 (5), 1003-1007, 2020 | 15 | 2020 |
| Reliability of serum tumor marker measurement to diagnose recurrence in patients with clinical stage I nonseminomatous germ cell tumors undergoing active surveillance: a … NH Chakiryan, A Dahmen, V Cucchiara, A Briganti, F Montorsi, A Salonia, ... The Journal of Urology 205 (6), 1569-1576, 2021 | 13 | 2021 |
| Misaligned Incentives in Benign Prostatic Enlargement Surgery: More Complex and Efficacious Procedures are Earning Fewer Relative Value Units DD Jiang, M Hayes, K Gillis, R Korets, AA Wagner, J Hedges, ... Journal of Endourology, 2020 | 12 | 2020 |
| RUC operative time estimates are inaccurate, resulting in decreased work RVU assignments for longer urologic procedures NH Chakiryan, DD Jiang, KA Gillis, Y Chen, AM Acevedo, KP Sajadi Urology 142, 94-98, 2020 | 11 | 2020 |
| Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma NH Chakiryan, Y Kim, A Berglund, A Chang, GJ Kimmel, A Hajiran, ... Journal for Immunotherapy of Cancer 11 (4), 2023 | 10 | 2023 |
| Will dynamic sentinel lymph node biopsy become the new international standard for evaluating high-risk penile cancer in patients with clinically negative lymph nodes? AM Aydin, NH Chakiryan, PE Spiess European Urology 78 (6), 873-874, 2020 | 10 | 2020 |
